EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Impact of Histopathological Diagnosis with Ancillary Immunohistochemical Studies on Lung Cancer Subtypes Incidence and Survival: A Population-Based Study

Andrea Bordoni, Massimo Bongiovanni, Luca Mazzucchelli, Alessandra Spitale

Journal of Cancer Epidemiology · 2011

DOI: 10.1155/2011/275758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Epidemiology, 2011. Verfasst von Andrea Bordoni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ticino Cancer Registry, Institute of Pathology, 6600 Locarno, Switzerland. andrea.bordoni@ti.ch. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The aim of this study was to assess the impact of immunohistochemical- (IHC-) studies on incidence and survival of lung cancer histotypes. Patients and Methods . Lung cancers occurred in southern Switzerland between 1996 and 2010 were selected by the Ticino Cancer Registry and categorised into adenocarcinoma (AC), squamous-cell-carcinoma (SqCC), small-cell-carcinoma (SmCC), and large-cell carcinoma/non-small-cell lung cancer (LCC/NSCLC). Incidence rates, annual-percentage-change (APC), and two-year overall survival (OS) (follow-up: 31.12.2010) were performed.

Results

2467 cases were selected: 997 (40.4%) AC; 522 (21.2%) LCC/NSCLC, 378 (15.3%) SmCC, and 570 (23.1%) SqCC. Trend-analysis showed significant increase in AC (APC: 4.6; 95% CI: 3.1; 6.0) and decrease of LCC/NSCLC, with significant joinpoint in 2003 (APC: −14.7; 95% CI: −21.6; −7.1). Improved OS and decreased OS were detected in SqCC and LCC/NSCLC, respectively.

Conclusions

This study highlights that diagnosis with ancillary immunohistochemical studies will change incidence and survival of precisely defined lung cancer subtypes. It calls attention to the need for cautious interpretation of studies and clinical trials, where the diagnosis was based on histology unaccompanied by IHC studies, and to the need of standardised diagnostic procedures.

Autor:innen und Institutionen

  • Ticino Cancer Registry, Institute of Pathology, 6600 Locarno, Switzerland. andrea.bordoni@ti.ch

Zitieren

APA

Bordoni, A., Bongiovanni, M., Mazzucchelli, L., & Spitale, A. (2011). Impact of Histopathological Diagnosis with Ancillary Immunohistochemical Studies on Lung Cancer Subtypes Incidence and Survival: A Population-Based Study. Journal of Cancer Epidemiology. https://doi.org/10.1155/2011/275758

Vancouver

Bordoni A, Bongiovanni M, Mazzucchelli L, Spitale A. Impact of Histopathological Diagnosis with Ancillary Immunohistochemical Studies on Lung Cancer Subtypes Incidence and Survival: A Population-Based Study. Journal of Cancer Epidemiology. 2011. doi:10.1155/2011/275758

BibTeX
@article{Bordoni2011,
  author = {Bordoni, Andrea and Bongiovanni, Massimo and Mazzucchelli, Luca and Spitale, Alessandra},
  title = {Impact of Histopathological Diagnosis with Ancillary Immunohistochemical Studies on Lung Cancer Subtypes Incidence and Survival: A Population-Based Study},
  journal = {Journal of Cancer Epidemiology},
  year = {2011},
  doi = {10.1155/2011/275758}
}
Kostenlos starten →